{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:03:03Z","timestamp":1778122983178,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaad.2019.03.062","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T02:55:14Z","timestamp":1553741714000},"page":"472-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review"],"prefix":"10.1016","volume":"81","author":[{"given":"Michael","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia S.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Drage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carilyn N.","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.03.062_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.1967.03120220053008","article-title":"Basement zone antibodies in bullous pemphigoid","volume":"200","author":"Jordon","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2019.03.062_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","article-title":"Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","article-title":"A population-based study of the association between bullous pemphigoid and neurologic disorders","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.det.2011.11.008","article-title":"Quality-of-life measurement in blistering diseases","volume":"30","author":"Sebaratnam","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2019.03.062_bib6","first-page":"CD002292","article-title":"Interventions for bullous pemphigoid","volume":"20","author":"Khumalo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2019.03.062_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.det.2011.06.021","article-title":"Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders","volume":"29","author":"Lehman","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2019.03.062_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2019.03.062_bib10","first-page":"66","article-title":"Prevalence and clinical features of Thai patients with bullous pemphigoid","volume":"29","author":"Kulthanan","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaad.2019.03.062_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"S\u00e1rdy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","article-title":"Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience","volume":"308","author":"Keller","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2019.03.062_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0923-1811(97)00067-4","article-title":"Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid","volume":"17","author":"Murakami","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2019.03.062_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0030-4220(81)90125-0","article-title":"Cicatricial pemphigoid: direct and indirect immunofluorescent studies","volume":"51","author":"Laskaris","year":"1981","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jaad.2019.03.062_bib17","series-title":"Blistering Diseases: Clinical Features, Pathogenesis, Treatment","first-page":"251","article-title":"Epidemiology of autoimmune bullous diseases","author":"Schmidt","year":"2015"},{"key":"10.1016\/j.jaad.2019.03.062_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaad.2017.10.035","article-title":"Nonbullous pemphigoid: a systematic review","volume":"78","author":"Lamberts","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.12936","article-title":"BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?","volume":"171","author":"Schmidt","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib22","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamadermatol.2013.756","article-title":"Bullous pemphigoid as pruritus in the elderly: a common presentation","volume":"149","author":"Bakker","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1034\/j.1600-0714.2003.00028.x","article-title":"Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid","volume":"32","author":"Caproni","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaad.2019.03.062_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archderm.135.5.569","article-title":"Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen","volume":"135","author":"Chan","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/000155500750012171","article-title":"Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid","volume":"80","author":"Konishi","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2019.03.062_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/jaut.2000.0437","article-title":"Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180","volume":"15","author":"Kromminga","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaad.2019.03.062_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1992.01680160075007","article-title":"Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses","volume":"128","author":"Rieckhoff-Cantoni","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archdermatol.2009.331","article-title":"Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects","volume":"146","author":"Wieland","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.03.062_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219305067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219305067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:49:38Z","timestamp":1759272578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219305067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0190962219305067"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.03.062","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.03.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}